<DOC>
	<DOCNO>NCT00003365</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use sulindac may effective way prevent colon cancer . Eating diet rich fruit vegetable appear reduce risk type cancer . Curcumin , rutin , quercetin compound find plant may prevent development colon cancer . PURPOSE : Randomized clinical trial study effectiveness sulindac , curcumin , rutin , quercetin prevent colon cancer .</brief_summary>
	<brief_title>Sulindac Plant Compounds Preventing Colon Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine response colonic epithelium normal volunteer average average risk colon cancer , give short term treatment plant phenolic curcumin , rutin , quercetin . - Compare colonic mucosal response plant phenolic response sulindac order evaluate whether share common mechanism colon cancer chemoprevention . - Determine low optimal dose three plant phenolic effective modulate biomarkers colon epithelial cell turnover , therefore , potentially inhibit colon cancer development . - Assess response colonic epithelium curcumin volunteer average risk colon cancer development . OUTLINE : This randomize , control , two part , single institution study . Patients Part B randomize gender . All patient undergo flexible sigmoidoscopic exam . - Part A : Patients , cohort 5-10 , receive one follow five treatment addition control diet : nothing ( arm I ) , oral sulindac twice day ( arm II ) , oral rutin 1 3 dos twice day ( arm III , IV , V ) , oral quercetin 1 3 dos twice day ( arm V , VI , VII ) , 1 3 dos oral curcumin twice day ( arm VIII , IX , X ) . Patients first randomize high dos rutin , quercetin , curcumin low dos may give order determine minimally effective dose . Treatment continue 6-10 week . - Part B : Patients randomize receive control diet ( arm I ) control diet plus oral curcumin twice day ( arm II ) 6-10 week . Patients follow every 2 week . PROJECTED ACCRUAL : There 130 patient ( 110 Part A 20 Part B ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<mesh_term>Sulindac</mesh_term>
	<mesh_term>Quercetin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Individuals average risk ( Parts A B ) average risk ( Part A ) development colon cancer Average risk individual define : No history colon adenomas No strong family history colon polyp cancer Above average risk individual define : History one sporadic adenomatous polyp least 0.5 cm size ( either tubular , tubulovillous , villous adenoma ) Have polypectomy refused procedure No significant family history adenomatous polyp , colon cancer , hereditary nonpolyposis colorectal cancer hereditary colon cancer syndrome Polyps focus adenocarcinoma within No history gastrointestinal cancer outside large bowel No gastrointestinal mucosal epithelial disease ( e.g. , Barrett 's esophagus , chronic recurrent peptic ulcer disease , celiac sprue , disorder nutrient absorption ) No significant asymptomatic lesion flexible sigmoidoscopy , inflammation , premalignancy malignancy PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : No platelet coagulation abnormalities No personal family history bleed disorder Hematopoietic concentration must due significant acute chronic disorder Hepatic : No liver disease Renal : No renal insufficiency Cardiovascular : No uncontrolled hypertension No chronic congestive heart failure No history endocarditis No history rheumatic fever No cardiac valve prostheses No mitral valve prolapse require antibiotic prophylaxis Other : HIV negative No gout No pancreatitis No chronic viral infection No significant acute uncontrolled chronic medical illness Generally nonsmoking ( 4 cigarette per week , i.e. , daily smoker ) Must abstain smoke least 1 month prior enrol study No alcohol consumption great 2 glass wine beer per day Normal weight ( 90120 % optimum body weight ) body habitus No change weight within 510 % body weight within past year No history inflammatory bowel disease ( either ulcerative colitis Crohn 's disease ) No hear equilibrium disorder No prior malignancy except resect carcinoma situ cervix nonmelanoma skin cancer No allergies sulindac tartrazine dye prior severe adverse reaction nonsteroidal antiinflammatory drug ( asthma , gastrointestinal bleeding , renal insufficiency ) No potential allergy curcumin , quercetin , rutin No gastrointestinal bleeding Not institutionalize , mentally disabled , incarcerated No unusually high intake store micronutrient high dos supplemental calcium folate Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No concurrent coumadin No chronic use nonsteroidal antiinflammatory drug ( unless stop 3 month ) No putative colon cancer chemoprevention agent ( unless stop 3 month )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>colon cancer</keyword>
</DOC>